Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in: | Journal of Virology Vol. 87; no. 8; pp. 4176 - 4184 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Society for Microbiology
01-04-2013
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | Drug resistance occurs through a series of subtle changes that maintain substrate recognition but no longer permit inhibitor binding. In HIV-1 protease, mutations at I50 are associated with such subtle changes that confer differential resistance to specific inhibitors. Residue I50 is located at the protease flap tips, closing the active site upon ligand binding. Under selective drug pressure, I50V/L substitutions emerge in patients, compromising drug susceptibility and leading to treatment failure. The I50V substitution is often associated with amprenavir (APV) and darunavir (DRV) resistance, while the I50L substitution is observed in patients failing atazanavir (ATV) therapy. To explain how APV, DRV, and ATV susceptibility are influenced by mutations at residue 50 in HIV-1 protease, structural and binding thermodynamics studies were carried out on I50V/L-substituted protease variants in the compensatory mutation A71V background. Reduced affinity to both I50V/A71V and I50L/A71V double mutants is largely due to decreased binding entropy, which is compensated for by enhanced enthalpy for ATV binding to I50V variants and APV binding to I50L variants, leading to hypersusceptibility in these two cases. Analysis of the crystal structures showed that the substitutions at residue 50 affect how APV, DRV, and ATV bind the protease with altered van der Waals interactions and that the selection of I50V versus I50L is greatly influenced by the chemical moieties at the P1 position for APV/DRV and the P2 position for ATV. Thus, the varied inhibitor susceptibilities of I50V/L protease variants are largely a direct consequence of the interdependent changes in protease inhibitor interactions. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI |
Author | Rajinthna M. Bandaranayake Ellen A. Nalivaika Nese Kurt Yilmaz Seema Mittal Celia A. Schiffer Madhavi N. L. Nalam Nancy M. King Moses Prabu-Jeyabalan |
Author_xml | – sequence: 1 fullname: Seema Mittal – sequence: 2 fullname: Rajinthna M. Bandaranayake – sequence: 3 fullname: Nancy M. King – sequence: 4 fullname: Moses Prabu-Jeyabalan – sequence: 5 fullname: Madhavi N. L. Nalam – sequence: 6 fullname: Ellen A. Nalivaika – sequence: 7 fullname: Nese Kurt Yilmaz – sequence: 8 fullname: Celia A. Schiffer |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23365446$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU1vFDEMhiNURLeFG2cU7kwb52uyF6Rt-eiiIhCUilvkzWQ6qTqZVZLZqr32jzPsQgUn2_Lj17LfA7IXh-gJeQnsCICb40-XyyMmpNEV8CdkBmxuKqVA7pEZY5xXSpif--Qg52vGQEotn5F9LoRWUz4jD99LGl0ZE95QjA296Hzqh-YuYh8cPcEcMh1auujXyUfchHT8DtO4zbb8ouA97spvfoILRudpiPRseVkB_ZqG4jF7ehtKRz-PBUsYYqZYtngzeqrYc_K0xZvsX_yJh-THh_cXp2fV-ZePy9PFeeWkqEvVTNdK5eRcGs61NmpV12beYgtGMCOB1Y3TDVeI4J1Q7WrloRHAwXjNPTpxSN7udNfjqveN87FMZ9t1Cj2mOztgsP93Yujs1bCxQnMpNJsE3uwEXBpyTr59nAVmf5thJzPs1gwLfMJf_bvvEf77_Ql4vQO6cNXdhuQt5t5eb4I1tTVWQq3FL35DlEo |
CitedBy_id | crossref_primary_10_3389_fmicb_2016_00061 crossref_primary_10_1080_07391102_2015_1018326 crossref_primary_10_1021_acs_biochem_9b00446 crossref_primary_10_1016_j_cplett_2018_06_040 crossref_primary_10_1073_pnas_1414063111 crossref_primary_10_1002_prot_24730 crossref_primary_10_1021_acs_jcim_5b00667 crossref_primary_10_7554_eLife_80328 crossref_primary_10_3390_molecules26030611 crossref_primary_10_1016_j_compbiomed_2022_105523 crossref_primary_10_1021_acs_jctc_9b00781 crossref_primary_10_1038_s41598_024_53940_1 crossref_primary_10_1002_jcc_27298 crossref_primary_10_1021_acsinfecdis_8b00336 crossref_primary_10_1039_C6RA09201B crossref_primary_10_1039_D1CP05075C crossref_primary_10_1016_j_tim_2016_03_010 crossref_primary_10_1021_acs_jctc_7b00601 crossref_primary_10_1021_acs_jcim_5b00173 crossref_primary_10_1021_acs_jctc_7b01109 |
Cites_doi | 10.1097/00002030-199912030-00006 10.1128/AAC.00574-10 10.1093/nar/gkg100 10.1007/978-1-4612-3374-9_13 10.1107/S0907444994003112 10.1021/jm049560p 10.1128/JVI.02531-09 10.1128/JVI.80.7.3607-3616.2006 10.1007/978-1-4615-5373-1_2 10.1345/aph.10423 10.1128/JVI.02706-06 10.1089/aid.1992.8.153 10.1128/jvi.69.9.5228-5235.1995 10.2217/17469600.1.3.291 10.1111/j.1747-0285.2008.00647.x 10.1128/AAC.01540-10 10.1016/S0021-9258(19)50290-3 10.1002/(SICI)1097-0134(199601)24:1<51::AID-PROT4>3.0.CO;2-R 10.1016/j.jviromet.2007.05.009 10.1128/AAC.49.9.3825-3832.2005 10.1021/bi2018317 10.1128/JVI.78.22.12446-12454.2004 10.1021/ct9004678 10.1128/AAC.44.8.2093-2099.2000 10.1016/S0969-2126(02)00720-7 10.1086/386291 10.1007/978-1-4757-9209-6_30 10.1128/JVI.78.21.12012-12021.2004 10.1016/S0076-6879(97)76066-X 10.1107/S0907444906005270 10.1110/ps.25502 10.1107/S0907444904019158 10.1038/374569a0 10.1021/jp2074804 10.1111/j.1742-4658.2010.07771.x |
ContentType | Journal Article |
Copyright | Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1128/JVI.03486-12 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 4184 |
ExternalDocumentID | 10_1128_JVI_03486_12 23365446 jvi_87_8_4176 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIH HHS grantid: S10 OD012028 – fundername: NIGMS NIH HHS grantid: P01-GM66524 – fundername: NCRR NIH HHS grantid: RR007707 – fundername: NCRR NIH HHS grantid: P41 RR007707 – fundername: NIGMS NIH HHS grantid: P01 GM066524 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAYJJ ABPPZ ACGFO ACNCT ADBBV AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK E3Z EBS ECM EIF EJD F20 F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A NPM O9- OHT OK1 P2P RHF RHI RNS RPM RSF TR2 UCJ UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c437t-d12845c4948226685b7789faf183084107dc6d25aa1ec35fbbe1d31218e62eac3 |
IEDL.DBID | RPM |
ISSN | 0022-538X |
IngestDate | Tue Sep 17 21:12:36 EDT 2024 Thu Nov 21 22:03:38 EST 2024 Sat Sep 28 08:39:49 EDT 2024 Wed May 18 15:26:13 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c437t-d12845c4948226685b7789faf183084107dc6d25aa1ec35fbbe1d31218e62eac3 |
Notes | S.M., R.M.B., and N.M.K. contributed equally to this article. Present address: Rajinthna M. Bandaranayake, Skirball Institute, New York University Medical School, New York, New York, USA; Moses Prabu-Jeyabalan, Department of Molecular Biology, The Commonwealth Medical, College, Scranton, Pennsylvania, USA. |
OpenAccessLink | https://jvi.asm.org/content/jvi/87/8/4176.full.pdf |
PMID | 23365446 |
PageCount | 9 |
ParticipantIDs | crossref_primary_10_1128_JVI_03486_12 pubmed_primary_23365446 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3624360 highwire_asm_jvi_87_8_4176 |
PublicationCentury | 2000 |
PublicationDate | 2013-04-01 |
PublicationDateYYYYMMDD | 2013-04-01 |
PublicationDate_xml | – month: 04 year: 2013 text: 2013-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2013 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 Tisdale M (e_1_3_2_13_2) 1999 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 Colonno R (e_1_3_2_16_2) 2004 Van Marck H (e_1_3_2_14_2) 2007; 12 Elston R (e_1_3_2_37_2) 2006; 11 e_1_3_2_9_2 e_1_3_2_15_2 DeLano WL (e_1_3_2_30_2) 2002 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_35_2 Roberts NA (e_1_3_2_5_2) 1995; 9 Henderson LE (e_1_3_2_7_2) 1988 |
References_xml | – ident: e_1_3_2_19_2 doi: 10.1097/00002030-199912030-00006 – ident: e_1_3_2_32_2 doi: 10.1128/AAC.00574-10 – ident: e_1_3_2_18_2 doi: 10.1093/nar/gkg100 – volume: 11 start-page: S102 year: 2006 ident: e_1_3_2_37_2 article-title: De-selection for the I50V mutation occurs in clinical isolates during Aptivus/r (tipranavir/ritonavir) based therapy publication-title: Antivir. Ther. contributor: fullname: Elston R – ident: e_1_3_2_28_2 doi: 10.1007/978-1-4612-3374-9_13 – volume-title: Abstr. Conf. Retroviruses Opportunistic Infect. year: 2004 ident: e_1_3_2_16_2 contributor: fullname: Colonno R – ident: e_1_3_2_25_2 doi: 10.1107/S0907444994003112 – ident: e_1_3_2_35_2 doi: 10.1021/jm049560p – ident: e_1_3_2_31_2 doi: 10.1128/JVI.02531-09 – ident: e_1_3_2_26_2 doi: 10.1128/JVI.80.7.3607-3616.2006 – ident: e_1_3_2_8_2 doi: 10.1007/978-1-4615-5373-1_2 – ident: e_1_3_2_9_2 doi: 10.1345/aph.10423 – ident: e_1_3_2_33_2 doi: 10.1128/JVI.02706-06 – volume: 9 start-page: S27 year: 1995 ident: e_1_3_2_5_2 article-title: Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors publication-title: AIDS contributor: fullname: Roberts NA – ident: e_1_3_2_2_2 doi: 10.1089/aid.1992.8.153 – ident: e_1_3_2_12_2 doi: 10.1128/jvi.69.9.5228-5235.1995 – ident: e_1_3_2_38_2 doi: 10.2217/17469600.1.3.291 – ident: e_1_3_2_39_2 doi: 10.1111/j.1747-0285.2008.00647.x – ident: e_1_3_2_42_2 doi: 10.1128/AAC.01540-10 – ident: e_1_3_2_22_2 doi: 10.1016/S0021-9258(19)50290-3 – ident: e_1_3_2_6_2 doi: 10.1002/(SICI)1097-0134(199601)24:1<51::AID-PROT4>3.0.CO;2-R – ident: e_1_3_2_15_2 doi: 10.1016/j.jviromet.2007.05.009 – ident: e_1_3_2_34_2 doi: 10.1128/AAC.49.9.3825-3832.2005 – ident: e_1_3_2_40_2 doi: 10.1021/bi2018317 – ident: e_1_3_2_21_2 doi: 10.1128/JVI.78.22.12446-12454.2004 – volume-title: Abstr. Sixth Conf. Retroviruses Opportunistic Infect. year: 1999 ident: e_1_3_2_13_2 contributor: fullname: Tisdale M – ident: e_1_3_2_41_2 doi: 10.1021/ct9004678 – ident: e_1_3_2_11_2 doi: 10.1128/AAC.44.8.2093-2099.2000 – ident: e_1_3_2_43_2 doi: 10.1016/S0969-2126(02)00720-7 – ident: e_1_3_2_17_2 doi: 10.1086/386291 – ident: e_1_3_2_4_2 doi: 10.1007/978-1-4757-9209-6_30 – volume: 12 start-page: S141 year: 2007 ident: e_1_3_2_14_2 article-title: Unraveling the complex resistance pathways of darunavir using the bioinformatics resistance determination (BIRD) publication-title: Antivir. Ther. contributor: fullname: Van Marck H – ident: e_1_3_2_10_2 doi: 10.1128/JVI.78.21.12012-12021.2004 – ident: e_1_3_2_24_2 doi: 10.1016/S0076-6879(97)76066-X – volume-title: Human retroviruses, cancer and AIDS: approaches to prevention and therapy. year: 1988 ident: e_1_3_2_7_2 contributor: fullname: Henderson LE – ident: e_1_3_2_27_2 doi: 10.1107/S0907444906005270 – ident: e_1_3_2_23_2 doi: 10.1110/ps.25502 – ident: e_1_3_2_29_2 doi: 10.1107/S0907444904019158 – ident: e_1_3_2_3_2 doi: 10.1038/374569a0 – ident: e_1_3_2_20_2 doi: 10.1021/jp2074804 – volume-title: The PyMol molecular graphics system. year: 2002 ident: e_1_3_2_30_2 contributor: fullname: DeLano WL – ident: e_1_3_2_36_2 doi: 10.1111/j.1742-4658.2010.07771.x |
SSID | ssj0014464 |
Score | 2.2629354 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... Drug resistance occurs through a series of subtle changes that maintain substrate recognition but no longer permit inhibitor binding. In HIV-1 protease,... |
SourceID | pubmedcentral crossref pubmed highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 4176 |
SubjectTerms | Anti-HIV Agents - pharmacology Atazanavir Sulfate Carbamates - pharmacology Crystallography, X-Ray Darunavir Drug Resistance, Viral HIV Protease - chemistry HIV Protease - genetics HIV-1 - drug effects HIV-1 - genetics Humans Kinetics Models, Molecular Mutant Proteins - chemistry Mutant Proteins - genetics Mutation, Missense Oligopeptides - pharmacology Point Mutation Protein Binding Protein Conformation Pyridines - pharmacology Sulfonamides - pharmacology Thermodynamics Vaccines and Antiviral Agents |
Title | Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50 |
URI | http://jvi.asm.org/content/87/8/4176.abstract https://www.ncbi.nlm.nih.gov/pubmed/23365446 https://pubmed.ncbi.nlm.nih.gov/PMC3624360 |
Volume | 87 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZYJKReqgJ9LAXkAz1mk_iReI_LSwsSFSot4mb5FTVVk0WbXaT2yh9n7KzR7pVbojhRlG_smcmMvw-hE6Ist74-OKbOS5g5l2hRFEmpiOHgb7Vhfu_w9K78_iDOLzxNDo97YULTvtH1qP3bjNr6d-itfGxMGvvE0tubM1h0GS2ydIAGEBvGFH1VOoD8hkWKcJjND7HbnYj0-v5qlFEmvPKMZwGmtODMh77rLinSBK-5pM12yTX_c_kBvV8FjnjSv-Au2nLtHtrppST_7aPnu0AE60k0sGotBvjnzcz2evP4VHV1h2cVnjSew1I91fP0XM2X4SiMnyzUf9Wf_nCdDyrBGnDd4unVfZLjW0_nAA4P-_-2-GbZF_A7rBZhuF06zLOP6Nflxc-zabISWEgMo-Uisd45ceMZYiAKKwTXZSnGlapgnmeCQWZoTWEJVyp3hvJKa5dbmkNU4AoCKzb9hLbbWeu-IOx1rTI1thpWUMbpWAuTO0KU01orllVD9C1-Y_nY82jIkH8QIQEWGWCRORmigwiAVF0j_zzVUpRSSJaXxRB97pF4fUSEcIjKDYxeB3j27M0rYFSBRXtlRAdvvvMrekeCNoZv4zlE2wCzO0KDzi6Pg0W-AFjO5fc |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswEB00KYrm0n1xuvHQHmVJXCT66GaB3cZB0KRBbgQ3oSoiObDsAO21P16SMgP7mpsEUoKAR86iGb4H8BlLw4yvD46I9RJm1iaKF0VSSqyZ87dKU392eHJenl7xwyNPk8PiWZjQtK9VPWyvm2Fb_wq9lTeNTmOfWHo2O3BGl5IiS3fgoduvWRaT9HXxwGU4NJKEu_Gr2O-OefrtcjrMCOVee8bzABNSMOqD302nFImCN5zSdsPkhgc6fnrPb38GT9YhJxr3w8_hgW1fwKNehPLPS_h3HihkPf0Gkq1BbuEsmrnplerRV9nVHZpXaNx49kt5Wy_SQ7lYhaswf7yUf2V_-8N2Phx16wjVLZpML5McnXkiCOcqkf_ji2arvvTfIbkM083KIpa9gp_HRxcHk2QtzZBoSsplYrxbY9pzy7j4reBMlSUfVbJyFiLj1OWURhcGMylzqwmrlLK5IbmLJ2yBna0nr2G3nbf2LSCviJXJkVHO9lJGRorr3GIsrVJK0qwawJeIjbjpGThEyFwwFw5OEeAUOR7AfgROyK4Rv29rwUvBBc3LYgBvegTvXhGhH0C5he3dBM-7vT3iIA3822sI9-_95Cd4PLmYnYiT6en3d7CHg8KGbwZ6D7sOcvsBdjqz-hhW9X_FVvt3 |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9NAFH6iRSAu7EtaCnOAo2N7FntyTJtGCdAqolD1NprNwgg7UZxUgit_nJlxHCXXcrM1z5al7_ktnufvA_iApWHG7w8OiPUSZtZGimdZlEusmcu3SlP_7_DkKr-84aNzT5OzlfoKQ_talf36V9Wvyx9htnJR6bibE4tnF2cu6FKSJfHCFPEB3HfvbIK7Rn2zgeC6HNoRhbv1m27mHfP40_W0nxDKvf6M5wImJGPUF8C7iakjC95JTPtDkztZaPzkP57_KTzelJ5o2Jo8g3u2fg4PWjHK3y_g71WgkvU0HEjWBjkHWlZz0yrWo1PZlA2aF2hYeRZMeVsu45FcrsNRsB-u5B_Znn61jS9LnT-hskaT6XWUopknhHApE_kvv-hi3Y4ANEiugrlZW8SSl_B9fP7tbBJtJBoiTUm-ioxPb0x7jhlXx2WcqTzng0IWLlIknLre0ujMYCZlajVhhVI2NSR1dYXNsIv55BUc1vPavgHklbESOTDKxWDKyEBxnVqMpVVKSZoUPfjY4SMWLROHCB0M5sJBKgKkIsU9OOrAE7KpxM_bUvBccEHTPOvB6xbF7S06-HuQ7-G7NfD82_srDtbAw72B8ejOV76Hh7PRWHyZXn4-hkc4CG34maC3cOgQtydw0Jj1u-DY_wC4Z_33 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+and+Thermodynamic+Basis+of+Amprenavir%2FDarunavir+and+Atazanavir+Resistance+in+HIV-1+Protease+with+Mutations+at+Residue+50&rft.jtitle=Journal+of+virology&rft.au=Mittal%2C+Seema&rft.au=Bandaranayake%2C+Rajinthna+M.&rft.au=King%2C+Nancy+M.&rft.au=Prabu-Jeyabalan%2C+Moses&rft.date=2013-04-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=87&rft.issue=8&rft.spage=4176&rft.epage=4184&rft_id=info:doi/10.1128%2FJVI.03486-12&rft_id=info%3Apmid%2F23365446&rft.externalDBID=PMC3624360 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |